EVITRADE HEALTH SYS CORP. (AXHLF: OTCQB) | EVITRADE Receives P.O. for 500 TULIP(TM) Systems and C.K. Cheung to Join Board of Directors


EVITRADE Receives P.O. for 500 TULIP(TM) Systems and C.K. Cheung to Join Board of Directors

Oct 22, 2016

OTC Disclosure News Service

Vancouver, BC, Canada

EVITRADE Health Receives P.O. for 500 TULIP™ Systems for Testing in Asia

Mr. C.K. Cheung to Join Board of Directors


VANCOUVER, BC, Friday, October 21,
2016 – EVITRADE Health Systems Corp. (CSE:EVA, OTCQB: AXHLF) (the “Company” or
announces it has received a purchase order of 500 Tulip™ units from a
Hong Kong based marketing group for testing purposes.  This initial manufacturing purchase order follows
almost immediately from the satisfactory testing of the system in Asia earlier
this week.

The company also announces that Mr. C.K. Cheung has been invited to join
the Board of Directors, subject to regulatory approvals.
Mr. Cheung has served as a forex head trader
in an investment bank before becoming an owner in a forex brokerage firm in
Taiwan, handling transactions with numerous international banks.  He went on to be in charge of Far East
District Forex and Currency Exchanges Platform in China, and is currently
serving as an Executive Director for the China Investment Trust Fund.

“I would like to thank Mr. C.K. Cheung and Mr. York Lau for their
assistance in securing this order, and am grateful that Mr. Cheung has accepted
the invitation to join the Board of Directors. 
We believe he is uniquely qualified to assist us at all levels, with his
extensive background in the financial world and his international business
acumen” said Sydney Au, Chairman and CEO



Sydney Au, Chairman CEO

EVITRADE Health Systems Corporation

(formerly Auxellence Health

Email: ceo@auxellence.com

Website: http://www.auxellence.com

CSE Micro-site: http://thecse.com/en/listings/technology/evitrade-health-systems-corp

About EVITRADE Health Systems Corporation (CSE:

EVITRADE (formerly Auxellence Health
Corp.), was founded in 2013 to provide online services for resolving common
health problems.

The company offers a physiologically
interactive computing platform that integrates medical devices and artificial intelligence
applications into a fully automated, personal health management system for
hypertension, arrhythmia, diabetes, and obesity.

The current focus is on the
normalization of cardiometabolic power in terms of blood pressure, blood
glucose, and body weight – and the monitoring of the physiological response to
medical solicitations, mainly medication, diet, exercise, and lifestyle

About TULIP™

The TULIP™ system is an online
self-service intended for adults interested in normalizing blood pressure,
heart rate and rhythm, blood glucose, and body weight. Measurement procedures,
conditioning protocols, and session schedules are prescribed automatically from
data acquired by the user’s TULIP™ device – a blood pressure monitor with
interactive protocols that can feed medical records and expert systems useful
in testing, tracking and treating common health conditions.

The Tulip™ medical device
has received Health Canada and CE Mark certifications.

– Forward Looking Statements

news release may contain forward-looking statements based on assumptions and
judgments of management regarding future events or results. Such statements are
subject to a variety of risks and uncertainties which could cause actual events
or results to differ materially from those reflected in the forward looking
statements. The company disclaims any intention or obligation to revise or
update such statements. For a description of the risks and uncertainties facing
the Company and its business and affairs, readers should refer to the Company’s
Management’s Discussion and Analysis and other disclosure filings with Canadian
securities regulators which is posted on

news release does not constitute an offer to sell or solicitation of an offer
to buy any of the securities described herein and accordingly undue reliance
should not be put on such. Neither the Canadian Securities Exchange (CSE or
CNSX Markets), nor its Regulation Services Provider (as that term is defined in
policies of the CSE) accepts responsibility for the adequacy or accuracy of
this release.

This news release does not constitute an offer to
sell or a solicitation of an offer to buy any of the securities described
herein in the United States. The securities described herein have not been
registered under the United States Securities Act of 1933, as amended (the
“U.S. Securities Act”), or any state securities law and may not be offered or
sold in the “United States”, as such term is defined in Regulation S
promulgated under the U.S. Securities Act, unless registered under the U.S. Securities
Act and applicable state securities laws or an exemption from such registration
requirements is available.

This release includes additional documents. Select the link(s) below to view.

EVA – PR Oct 21 2016_FINAL_V.3_Manufacturing P.O. of 500 Systems for Asian and C.K. CHEUNG to join Board.pdf

Copyright © 2016 OTC Markets. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Leave a Reply